Nurse Navigator Program for High-Risk Patients Undergoing Joint Replacement

This study is looking at whether a Nurse Navigator Program can help reduce hospital readmissions for patients considered high-risk after having a total or partial hip or knee replacement. High-risk patients are those with conditions like heart failure (HF), chronic obstructive pulmonary disease (COPD), or who are on dialysis. The Nurse Navigator Program involves a team of nurses who identify specific chronic conditions and suggest management care to primary care physicians, as well as referring patients to specialists. The study aims to see if this educational support leads to fewer hospital readmissions and if patients are satisfied with the program. We don't know the current recruitment status, but the study plans to enroll 300 participants.

Study design
This interventional study plans to enroll 300 participants. It compares patients who receive the Nurse Navigator Program to those who do not.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for readmission rates for one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05592847

A Study of the Effect of a Nurse Navigator Program on High Risk Patients

Not Yet Recruiting
NAAges 18+InterventionalSupportive care
Mayo Clinic
~300 participants
Updated 2026-03-19 on ClinicalTrials.gov
What's tested:Nurse Navigator Program

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Readmission rates
Measured over One year
Patient Readmission
Arthroplasty, Replacement, Knee
Arthroplasty, Replacement, Hip
Heart Failure
Pulmonary Disease, Chronic Obstructive
Renal Insufficiency
Body Mass Index
Alcoholism
1 sites across 1 states
Florida1
  • George Pujalte, MD · PRINCIPAL_INVESTIGATOR · Mayo Clinic

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Readmission ratesOne year